ArticleEcancermedicalscience2026
Long-term overall survival of testicular cancer: findings from a rural population-based cancer registry, Ratnagiri district, Maharashtra state, India.
Article in Ecancermedicalscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tata Memorial Centre (TMC) in collaboration with Bhaktashreshtha Kamalakarpant Laxman Walawalkar Hospital (BKLWH), Dervan, a rural cancer hospital in Ratnagiri, started a population-based cancer registry (PBCR) in Ratnagiri district, Maharashtra, India in February 2009. Testicular cancer survival is a less-explored area of oncology research. This paper aims to present the 10-year survival of testicular cancer patients in Ratnagiri district for the years 2009-2018. Methods: The registry follows an active method of case registration. Major sources of the cancer registry are TMC and BKLWH. Data quality control was conducted by TMC, Mumbai. Follow-up was performed by house and village visits/phone calls by registry staff. For survival analysis, the date of diagnosis was the starting date, and the last follow-up date was 31 December 2023. The 5-year and 10-year overall survival was calculated using the Kaplan-Meier method and relative survival (RS) by the Pohar Perme method. Results: A total of 43 testicular cancer cases were registered in Ratnagiri PBCR, with incidence and mortality rates of 0.6 and 0.2 per 100,000 population. The 10-year RS of testicular cancer was 63.3% (95% confidence interval: 45.4-76.7). Survival was 100% for localised cases. Other prognostic factors were age at diagnosis (<40 years), histology (seminoma), 'surgery' as a treatment modality and 'completed' treatment status. Conclusion: Good health infrastructure and linkage of rural hospitals with the tertiary cancer centre play a pivotal role in improved testicular cancer outcomes. Continued efforts in research and education for health professionals serving as the first point of contact for the population will be essential to enhance testicular management in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.